Alaunos Therapeutics (TCRT) Cash from Investing Activities (2009 - 2025)
Alaunos Therapeutics (TCRT) reported Cash from Investing Activities of -$1000.0 for Q4 2025, down 100.07% quarter-over-quarter from $1.5 million in Q4 2023.
Alaunos Therapeutics (TCRT) Cash from Investing Activities (2009 - 2025) Analysis & Trends
Alaunos Therapeutics has reported Cash from Investing Activities for 16 years, with the latest figure at -$1000.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Investing Activities changed N/A year-over-year to -$1000.0; the trailing twelve-month figure through Dec 2025 stood at -$1000.0 (changed N/A YoY), and the FY2025 full-year result was -$98000.0, changed N/A from the prior year.
- Cash from Investing Activities for Q4 2025 stood at -$1000.0, down from $1.5 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $1.5 million in Q4 2023, with the low at -$1.9 million in Q2 2021.
- Historically, Cash from Investing Activities has averaged -$167000.0 across 4 years, with a median of -$57000.0 in 2022.
- The largest YoY upside for Cash from Investing Activities was 1716.13% in 2023 against a maximum downside of 136.84% in 2023.
- Alaunos Therapeutics' Cash from Investing Activities stood at -$359000.0 in 2021, then soared by 74.09% to -$93000.0 in 2022, then surged by 1716.13% to $1.5 million in 2023, then slumped by 100.07% to -$1000.0 in 2025.
- The last three Cash from Investing Activities figures came in at -$1000.0 (Q4 2025), $1.5 million (Q4 2023), and $1000.0 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.89 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 638.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -431.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 579,519.10 |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2023 | 1.50 Mn |
| Dec 31, 2023 | 1.50 Mn |
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | -135,000.00 |
| Jun 30, 2023 | -135,000.00 |
| Mar 31, 2023 | -23,000.00 |
| Mar 31, 2023 | -23,000.00 |
| Dec 31, 2022 | -93,000.00 |
| Dec 31, 2022 | -93,000.00 |
| Sep 30, 2022 | -14,000.00 |
| Sep 30, 2022 | -14,000.00 |
| Jun 30, 2022 | -57,000.00 |
| Jun 30, 2022 | -57,000.00 |
| Mar 31, 2022 | -29,000.00 |
| Mar 31, 2022 | -29,000.00 |
| Dec 31, 2021 | -359,000.00 |
| Dec 31, 2021 | -359,000.00 |